Thomas Hamilton
Vermögen: 5 Mio $ am 31.05.2026
Vermögen: 5 Mio $ am 31.05.2026
Der Gründer der CureFA Foundation, Thomas Edward Hamilton, bekleidet derzeit die Position des Chairman bei Chondrial Therapeutics, Inc. und Chairman bei Chondrial Therapeutics Holdings LLC sowie President & Chief Executive Officer bei Construction Forms, Inc. Herr Hamilton ist außerdem Mitglied des Vorstands von Annaly Capital Management, Inc. (ehemaliger Vorsitzender), The Friedreich's Ataxia Research Alliance und Larimar Therapeutics, Inc. In der Vergangenheit hatte Herr Hamilton die Position eines Managing Director bei Citigroup, Inc. und eines Managing Director bei Salomon Brothers, Inc. (eine Tochtergesellschaft der Citigroup, Inc.) und Head of Securitized Products Trading bei Barclays Capital, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.05.2026 | 824.231 ( 0,96 % ) | 3 Mio $ | 31.05.2026 | |
| 10.06.2026 | 115.000 ( 0,02 % ) | 3 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.05.2020 |
| ANNALY CAPITAL MANAGEMENT, INC. | Vorsitzender | 06.03.2019 |
Construction Forms, Inc.
Construction Forms, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Designs, manufactures and delivers concrete pumping & placing equipment | Direktor/Vorstandsmitglied | 01.01.2013 |
The Friedreich's Ataxia Research Alliance
The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services Provides patient registry services | Direktor/Vorstandsmitglied | - |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Vorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan drugs for mitochondrial diseases | Vorsitzender | 01.05.2020 |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Trading-Equity | 01.05.2013 |
Salomon Brothers, Inc.
Salomon Brothers, Inc. Investment Banks/BrokersFinance Investment banking services | Corporate Officer/Principal | - |
| CITIGROUP INC. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Annaly Capital Management, Inc.
Annaly Capital Management, Inc. Real Estate Investment TrustsFinance Operates as real estate investment trust which invests in residential mortgage-backed securities | Finance |
Citigroup, Inc.
Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan drugs for mitochondrial diseases | Health Technology |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Construction Forms, Inc.
Construction Forms, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Designs, manufactures and delivers concrete pumping & placing equipment | Producer Manufacturing |
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salomon Brothers, Inc.
Salomon Brothers, Inc. Investment Banks/BrokersFinance Investment banking services | Finance |
The Friedreich's Ataxia Research Alliance
The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services Provides patient registry services | Technology Services |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
CureFA Foundation | |
Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen